DaVita Inc. DVA
Set alert
At close · Oct 30
After hours · Oct 30, 4:20 PM ET
- YTD
- +65.04%
- 1 year
- +57.89%
- Open
- 175.00
- Prev close
- 193.31
- Mkt cap
- 11.96B
- Vol
- 1.76M
- Avg vol
- 807.76K
- EPS
- 11.84
- P/E
- 15.84
- Div yield
- 0.00%
More statistics
- Low
- 173.28
- High
- 187.77
- Forward P/E
- 10.95
- Beta
- 0.80
- Short ratio
- 7.53
- Inst. own
- 48.43%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 1, 2027
- 50-d avg
- 181.16
- 200-d avg
- 176.60
- 1y target
- 219.86
5D chart
Events in this range
- Oct 29, 2026Earnings: 3.82; estimate 3.57; surprise 7%
Signals (139)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:55 PM | 1 day ago |
| SMA: Bearish | Oct 30, 3:35 PM | 1 day ago |
| MACD: Sell Signal | Oct 30, 3:30 PM | 1 day ago |
| RSI: Overbought | Oct 30, 3:20 PM | 1 day ago |
| RSI: Overbought | Oct 30, 2:50 PM | 1 day ago |
| RSI: Overbought | Oct 30, 2:05 PM | 1 day ago |
| SMA: Bullish | Oct 30, 1:10 PM | 1 day ago |
| SMA: Bearish | Oct 30, 1:05 PM | 1 day ago |
| SMA: Bullish | Oct 30, 12:40 PM | 1 day ago |
| SMA: Bearish | Oct 30, 12:30 PM | 1 day ago |
| SMA: Bullish | Oct 30, 12:15 PM | 1 day ago |
| SMA: Bullish | Oct 30, 12:15 PM | 1 day ago |
| SMA: Bullish | Oct 30, 11:50 AM | 1 day ago |
| SMA: Bearish | Oct 30, 11:45 AM | 1 day ago |
| SMA: Bullish | Oct 30, 11:25 AM | 1 day ago |
| RSI: Oversold | Oct 30, 11:20 AM | 1 day ago |
| SMA: Bearish | Oct 30, 10:45 AM | 1 day ago |
| MACD: Buy Signal | Oct 30, 10:35 AM | 1 day ago |
| SMA: Bullish | Oct 30, 10:15 AM | 1 day ago |
| RSI: Oversold | Oct 30, 9:35 AM | 1 day ago |
| SMA: Bearish | Oct 30, 9:30 AM | 1 day ago |
| SMA: Bullish | Oct 29, 3:55 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:50 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:45 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:10 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:10 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:05 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:05 PM | 2 days ago |
| SMA: Bearish | Oct 29, 2:50 PM | 2 days ago |
| SMA: Bearish | Oct 29, 2:50 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 2:50 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 2:35 PM | 2 days ago |
| SMA: Bullish | Oct 29, 2:20 PM | 2 days ago |
| SMA: Bearish | Oct 29, 2:15 PM | 2 days ago |
| SMA: Bullish | Oct 29, 2:10 PM | 2 days ago |
| SMA: Bearish | Oct 29, 2:05 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 2:05 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 1:55 PM | 2 days ago |
| SMA: Bullish | Oct 29, 1:35 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:30 PM | 2 days ago |
| SMA: Bullish | Oct 29, 1:05 PM | 2 days ago |
| SMA: Bullish | Oct 29, 1:05 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:00 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:00 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:30 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:10 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:05 PM | 2 days ago |
| SMA: Bearish | Oct 29, 11:55 AM | 2 days ago |
| SMA: Bullish | Oct 29, 11:45 AM | 2 days ago |
| SMA: Bearish | Oct 29, 11:40 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 11:30 AM | 2 days ago |
| SMA: Bullish | Oct 29, 11:25 AM | 2 days ago |
| SMA: Bearish | Oct 29, 11:20 AM | 2 days ago |
| RSI: Overbought | Oct 29, 10:40 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:05 AM | 2 days ago |
| SMA: Bearish | Oct 29, 9:50 AM | 2 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 2 days ago |
| MACD: Buy Signal | Oct 28, 3:25 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:20 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:20 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 2:55 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 2:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:30 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:30 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 2:15 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:10 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:10 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 1:55 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:50 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:50 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:20 PM | 3 days ago |
| SMA: Bearish | Oct 28, 12:30 PM | 3 days ago |
| SMA: Bullish | Oct 28, 12:20 PM | 3 days ago |
| SMA: Bearish | Oct 28, 12:15 PM | 3 days ago |
| SMA: Bearish | Oct 28, 12:00 PM | 3 days ago |
| SMA: Bullish | Oct 28, 11:40 AM | 3 days ago |
| SMA: Bearish | Oct 28, 11:05 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 11:05 AM | 3 days ago |
| RSI: Overbought | Oct 28, 10:35 AM | 3 days ago |
| SMA: Bullish | Oct 28, 10:15 AM | 3 days ago |
| SMA: Bearish | Oct 28, 10:05 AM | 3 days ago |
| SMA: Bullish | Oct 28, 9:35 AM | 3 days ago |
| RSI: Overbought | Oct 28, 9:35 AM | 3 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 3 days ago |
| SMA: Bullish | Oct 27, 3:40 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:35 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:50 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:50 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:35 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:25 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:00 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:00 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:55 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:45 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:20 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:20 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:10 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:10 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:55 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:25 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:05 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:00 PM | 4 days ago |
| SMA: Bearish | Oct 27, 11:55 AM | 4 days ago |
| SMA: Bullish | Oct 27, 11:50 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 11:50 AM | 4 days ago |
| RSI: Oversold | Oct 27, 10:50 AM | 4 days ago |
| SMA: Bearish | Oct 27, 10:00 AM | 4 days ago |
| SMA: Bearish | Oct 27, 10:00 AM | 4 days ago |
| MACD: Sell Signal | Oct 27, 10:00 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:55 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 9:55 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:50 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:40 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:40 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 26, 3:40 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 3:40 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:25 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:20 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:20 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:15 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:15 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:40 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:20 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:20 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 2:00 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 1:45 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:30 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:20 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 1:20 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:45 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:40 PM | 5 days ago |
| SMA: Bearish | Oct 26, 10:50 AM | 5 days ago |
| SMA: Bullish | Oct 26, 10:45 AM | 5 days ago |
| SMA: Bearish | Oct 26, 10:40 AM | 5 days ago |
News
1 day ago zacks.com
DaVita Q3 Earnings Beat Estimates on IKC Strength, Revenues Rise Y/Y
DVA's Q3 earnings surge 52.2% as revenues rise 4.6%, fueled by strong kidney care and international growth despite rising costs and margin pressure.
1 day ago marketbeat.com
What DaVita (DVA) Said on Its Q3 Earnings Call
DaVita NYSE: DVA reported third-quarter adjusted operating income of $561 million, adjusted earnings per share of $3.82 and free cash flow of $276 million, while narrowing its full-year 2026 outlook.…
2 days ago seekingalpha.com
DaVita Inc. (DVA) Q3 2026 Earnings Call Transcript
DaVita Inc. (DVA) Q3 2026 Earnings Call Transcript
2 days ago zacks.com
DaVita HealthCare (DVA) Beats Q3 Earnings and Revenue Estimates
DaVita HealthCare (DVA) came out with quarterly earnings of $3.82 per share, beating the Zacks Consensus Estimate of $3.78 per share. This compares to earnings of $2.51 per share a year ago.
2 days ago benzinga.com
DaVita Q3 2026 Earnings Call Transcript
DaVita (NYSE:DVA) reported third-quarter financial results on Thursday. The transcript from the company's third-quarter earnings call has been provided below.
2 days ago benzinga.com
DaVita Q3 2026 Earnings Call Transcript
DaVita (NYSE:DVA) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
-
2 days ago benzinga.com
DaVita Q3 Adj. EPS $3.82 Beats $3.61 Estimate, Sales $3.578B Beat $3.508B Estimate
DaVita (NYSE:DVA) reported quarterly earnings of $3.82 per share which beat the analyst consensus estimate of $3.61 by 5.82 percent. This is a 52.19 percent increase over earnings of $2.51 per share…
2 days ago prnewswire.com
DaVita Inc. 3rd Quarter 2026 Results
DENVER, Oct. 29, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2026. Financial and operating highlights for the quarter…
2 days ago prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DaVita Inc. - DVA
NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DaVita Inc. ("DaVita" or the "Company") (NYSE: DVA). Such investors are advised to contact…
4 days ago globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DaVita Inc. - DVA
NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of DaVita Inc. (“DaVita” or the “Company”) (NYSE: DVA). Such investors are advised to contact…
4 days ago zacks.com
Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends?
DVA's Q3 2026 earnings are expected to rise on improving treatment volumes and cost discipline, but reimbursement pressures could weigh on profitability.
4 days ago prnewswire.com
DaVita Brings Preventive Health Screenings Into Communities to Help Identify Hidden Health Risks
Nearly 1,000 people screened in Houston and Los Angeles, with a majority showing signs of elevated chronic disease risk DENVER, Oct. 27, 2026 /PRNewswire/ -- Millions of Americans are living with…
1 week ago zacks.com
DaVita HealthCare (DVA) Falls More Steeply Than Broader Market: What Investors Need to Know
DaVita HealthCare (DVA) closed at $183.64 in the latest trading session, marking a -1.32% move from the prior day.
1 week ago zacks.com
DaVita Stock Gains 55.6% Year to Date: What's Behind the Rally?
DaVita's 55.6% stock rally reflects stronger operating execution, improving treatment volumes and value-based kidney care gains despite reimbursement pressures.
1 week ago defenseworld.net
DaVita Inc. $DVA Position Lifted by CWA Asset Management Group LLC
CWA Asset Management Group LLC grew its stake in DaVita Inc. (NYSE: DVA) by 15.9% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The…
1 week ago benzinga.com
Health Care Stocks Hit Record Highs, GM Drops Nearly 8%: Stock Market Today
Health care stocks climbed to record highs by midday Tuesday, with defensives and small caps leading a recovery from an early dip.
1 week ago prnewswire.com
DaVita Inc. Schedules 3rd Quarter 2026 Investor Conference Call
DENVER, Oct. 19, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Thursday, October 29, 2026, at 5:00…
1 week ago defenseworld.net
18,685 DaVita Inc. $DVA Shares Acquired by Counterpoint Mutual Funds LLC
Counterpoint Mutual Funds LLC lifted its holdings in shares of DaVita Inc. (NYSE: DVA) by 56.3% in the undefined quarter, according to the company in its most recent disclosure with the Securities…
2 weeks ago prnewswire.com
DaVita Brings New Clinical Research to ASN Kidney Week 2026, Advancing Evidence for the Next Era of Kidney Care
Seven studies spanning middle molecule clearance, home dialysis and patient experience highlight DaVita's commitment to translating innovation into better care DENVER, Oct. 15, 2026 /PRNewswire/ --…
3 weeks ago zacks.com
Why DaVita HealthCare (DVA) Outpaced the Stock Market Today
In the latest trading session, DaVita HealthCare (DVA) closed at $179.25, marking a +1.26% move from the previous day.
3 weeks ago seekingalpha.com
DaVita: After A 25% Drop, The Buyback Machine Is Cheap Again
DaVita is rated Buy with a $220 12-month price target, offering 22% upside from current levels. Despite flat industry volumes and Medicare rate headwinds, DVA's aggressive buybacks drive most EPS…
3 weeks ago zacks.com
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
DaVita gains from IKC growth, improving treatment economics and stronger formulary adoption, but payer-mix pressures and costs remain concerns.
3 weeks ago prnewswire.com
DaVita Activates Emergency Response Efforts Ahead of Hurricane Isaias, Urges Kidney Patients to Prepare Early
Patients encouraged to confirm treatment schedules, prepare emergency supplies and contact DaVita for assistance DENVER, Oct. 8, 2026 /PRNewswire/ -- As Hurricane Isaias approaches the Gulf Coast and…
3 weeks ago benzinga.com
Michael Burry Warns Anthropic’s Valuation Could Buy 78 Profitable S&P 500 Companies: ‘Fun Game in Times Like These’
Michael Burry calls Anthropic's valuation a 'bubble,' noting it could buy 78 profitable S&P 500 companies like Domino's and Clorox.
1 month ago benzinga.com
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
1 month ago benzinga.com
Warren Buffett, Donald Trump Bet on Same 17 Stocks — Some Might Surprise You
The investment portfolio of President Donald Trump and Berkshire Hathaway have 17 stocks in common. Here's a look at the list.
1 month ago benzinga.com
DaVita Reaches Preliminary Settlement Class Agreement Following Ransomware Attack
A federal court preliminarily approves a class action settlement for 2.3 million patients affected by the DaVita ransomware attack.
2 months ago benzinga.com
Berkshire Hathaway Cut Capital One Stake by 58% in Q2 — Billionaire Dan Loeb Is Doing the Exact Opposite
Berkshire slashed its Capital One stake by 58%, among its largest cuts, despite the stock's top growth score.
-
2 months ago benzinga.com
DaVita Enters Value-Based Care Agreement With Humana Medicare Advantage To Provide Care To Members With Chronic Kidney Disease Stages 3B–5
Launched July 1, this partnership builds on the organizations' long-standing collaboration in end stage kidney disease and expands earlier into the disease journey, when intervention can have the…
-
2 months ago benzinga.com
TD Cowen Upgrades DaVita to Buy, Lowers Price Target to $220
TD Cowen analyst Ryan Langston upgrades DaVita (NYSE:DVA) from Hold to Buy and lowers the price target from $201 to $220.
2 months ago benzinga.com
The Economy Lost Jobs, Wall Street Threw a Party: What Moved Markets This Week
US payrolls shrank by 23K in July. Here is how weak jobs data sparked gains for tech, gold, and top weekly movers.
-
2 months ago benzinga.com
Truist Securities Maintains Hold on DaVita, Lowers Price Target to $215
Truist Securities analyst David Macdonald maintains DaVita (NYSE:DVA) with a Hold and lowers the price target from $250 to $215.
2 months ago benzinga.com
Gold Jumps 4%, Dow Jones Smashes Record Highs: Stock Market Today
Gold posts its biggest one-day gain since February and the Dow sets a record as Iran deal hopes cool inflation fears.
2 months ago benzinga.com
Toast To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Wall Street analysts changed outlook on top names. UBS cut Fidelity National Information target, JP Morgan downgraded Ball, Needham raised Hinge Health.
2 months ago benzinga.com
SpaceX, Teradata, Pinterest And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
U.S. stock futures mixed, Dow up 100 points. SpaceX stock falls 10.3% after reporting strong Q2 revenue but a loss. Other stocks also decline.
-
2 months ago benzinga.com
Barclays Maintains Equal-Weight on DaVita, Raises Price Target to $224
Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and raises the price target from $218 to $224.
-
2 months ago benzinga.com
DaVita Q2 Adj. EPS $4.02 Beats $3.88 Estimate, Sales $3.554B Beat $3.496B Estimate
DaVita (NYSE:DVA) reported quarterly earnings of $4.02 per share which beat the analyst consensus estimate of $3.88 by 3.61 percent. This is a 36.27 percent increase over earnings of $2.95 per share…
-
3 months ago benzinga.com
Truist Securities Maintains Hold on DaVita, Raises Price Target to $250
Truist Securities analyst David Macdonald maintains DaVita (NYSE:DVA) with a Hold and raises the price target from $205 to $250.
-
3 months ago benzinga.com
Barclays Maintains Equal-Weight on DaVita, Raises Price Target to $218
Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and raises the price target from $194 to $218.
-
4 months ago benzinga.com
8 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
-
5 months ago benzinga.com
TD Cowen Maintains Hold on DaVita, Raises Price Target to $201
TD Cowen analyst Ryan Langston maintains DaVita (NYSE:DVA) with a Hold and raises the price target from $144 to $201.
-
5 months ago benzinga.com
Truist Securities Maintains Hold on DaVita, Raises Price Target to $205
Truist Securities analyst David Macdonald maintains DaVita (NYSE:DVA) with a Hold and raises the price target from $158 to $205.
-
5 months ago benzinga.com
Barclays Maintains Equal-Weight on DaVita, Raises Price Target to $194
Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and raises the price target from $158 to $194.
5 months ago benzinga.com
S&P 500, Nasdaq 100 Smash Records As AMD Jumps 16% On AI Hype: Stock Market Today
U.S. stocks hit records as Trump's Iran memo sinks oil 6%, AMD soars 17% on data-center beat.
5 months ago benzinga.com
This AMD Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Top Wall Street analysts upgraded several top stocks. See all changes and ratings on Benzinga's analyst ratings page. Analysts are bullish on AMD.
5 months ago benzinga.com
Davita, Bloomin' Brands, Compass And Other Big Stocks Moving Higher On Wednesday
Dow Jones up 500 points, DaVita Inc (DVA) shares rise after better-than-expected earnings and raised guidance. Other gaining stocks include EVC, BLMN, MNKD, FLEX, HUT, AVTX, COMP, VCYT, and SSRM.
-
5 months ago benzinga.com
Deutsche Bank Upgrades DaVita to Buy, Raises Price Target to $220
Deutsche Bank analyst Pito Chickering upgrades DaVita (NYSE:DVA) from Hold to Buy and raises the price target from $126 to $220.
-
5 months ago benzinga.com
DaVita Q1 Adj. EPS $2.87 Beats $2.32 Estimate, Sales $3.416B Beat $3.356B Estimate
DaVita (NYSE:DVA) reported quarterly earnings of $2.87 per share which beat the analyst consensus estimate of $2.32 by 23.71 percent. This is a 43.5 percent increase over earnings of $2.00 per share…
8 months ago benzinga.com
Buffett's Final Filing: Berkshire Initiates New York Times Stake, Slashes Amazon Position Before CEO Transition
The latest 13F filing from Berkshire Hathaway reveals some of the final position changes made by Warren Buffett as CEO.